Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P378 | DOI: 10.1530/endoabs.110.P378

ECEESPE2025 Poster Presentations Diabetes and Insulin (143 abstracts)

Cross sectional and longitudinal study of arterial stiffness in pediatric patients with type 1 diabetes mellitus (T1DM), with glycemic metrics derived from continuous glucose monitoring (CGM) devices

Eirini Georeli 1 , Georgia Sotiriou 2 , Athanasia Chainoglou 2 , Stella Stabouli 2 , Assimina Galli-Tsinopoulou 3 , 4 & Athanasios Christoforidis 2


1General Hospital Kavala, Paediatric, Kavala, Greece; 2School of Medicine Faculty of Health Sciences, Aristotle University of Thessaloniki, 1st Department of Paediatrics, Hippokratio General Hospital, Thessaloniki, Greece; 3School of Medicine Faculty of Health Sciences, Aristotle University of Thessaloniki, Unit of Pediatric Endocrinology and Metabolism, 2nd Department of Paediatrics, AHEPA General Hospital, Thessaloniki, Greece; 4School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 2nd Department of Pediatrics, University General HOspital AHEPA, Thessaloniki, Greece


JOINT2066

Aim: To investigate early indicators of cardiovascular disease (CVD) in youths with type 1 diabetes mellitus (T1DM), focusing on pulse wave velocity (cfPWV) and augmentation index (AIx@75) and their associations with various glycemic parameters and new metrics derived from continuous glucose monitoring (CGM) systems.

Patients and Methods: The study had two parts: for the cross-sectional part, 124 youths with T1DM (58 boys, mean age: 10. 75 ± 3. 57 years and mean disease duration: 3. 09 ± 2. 91years) were assessed, whereas for the longitudinal part, 87 patients (44 boys, mean age 10. 72 ± 3. 35 years and mean disease duration: 3. 27 ± 2. 84 years at the first assessment), completed 3 visits with a six month interval. In each visit, cfPWV and AIx@75 were quantified using a validated non – invasive method, while glycemic parameters such as HbA1c, time in range (TIR), time above range (TAR) and time below range (TBR) were assessed during the last 3 months from the assessment. For the longitudinal part patients were divided in 2 groups: TIR improvers: patients with constantly TIR≥ 70% or constantly TIR ≥ 60% and improved by + ≥ 10% from the beginning of the study vs TIR non-improvers and HbA1c improvers: patients with constantly HbA1c ≤ 7% or constantly HbA1c ≤ 8% and improved by -≥0. 8% from the beginning vs HbA1c non-improvers. Univariate and multivariate linear regression were used to explore the association of cfPWV and AIx@75 with glycemic variables.

Results: In the cross-sectional study all arterial stiffness parameters were significantly correlated with systolic and diastolic blood pressure (SBP, DBP), whereas AIx@75 was negatively correlated with TIR (r = - 0. 190, P = 0. 034) and positively correlated with TAR (r = 0. 212, P = 0. 018). In the longitudinal study, TIR improvers had lower PWV values (P = 0. 013) at the 3rd assessment compared to TIR non-improvers and showed significant improvement in ΔPWV Z score according to age (P = 0. 022) and ΔSBPindex (P = 0. 036). Finally, no significant difference regarding arterial stiffness parameters was shown between HbA1c improvers and HbA1c non-improvers.

Conclusion: Higher Alx@75 values were significantly correlated to lower TIR and higher TAR values. Children and adolescents who had TIR in the suggested target or improved their TIR, showed significantly lower PWV values in their final assessment and significantly improved both PWV and SBP. Such a finding was not shown when HbA1c was used as a metric of glycemia, indicating TIR as a more sensitive index for CVD.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches